Vimarsana
Biggest News Aggregation in the World

Daniela Kalthoff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniela Kalthoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniela Kalthoff Today - Breaking & Trending Today

Extinct animal's RNA extracted in world first - Vimarsana News

Extinct animal's RNA extracted in world first

STOCKHOLM: Scientists have, for the first time, recovered RNA from an extinct species, the Tasmanian tiger, raising hope for the resurrection of animals once thought lost forever, researchers from Stockholm University told Agence France-Presse (AFP).

RNA recovered from extinct animal in world first - Vimarsana News

RNA recovered from extinct animal in world first

Scientists have focused their de-extinction efforts on the Tasmanian tiger as its natural habitat in Tasmania is largely preserved.

Scientists take step toward "being able to resurrect extinct species" - Vimarsana News

Scientists take step toward "being able to resurrect extinct species"

"People didn't think it could really be done," Marc Friedländer, an associate professor in molecular biology at Stockholm University, told CBS News.

Source: yahoo.com
RNA recovered from extinct animal | Borneo Bulletin Online - Vimarsana News

RNA recovered from extinct animal | Borneo Bulletin Online

STOCKHOLM (AFP) – Scientists have for the first time recovered RNA from an extinct species, the Tasmanian tiger, raising hope for the resurrection of animals once thought lost forever, Stockholm University researchers told AFP. “RNA has never been extracted and sequenced from an extinct species before,” said Stockholm University professor of evolutionary genomics Love Dalen, […]

In a first, scientists recover RNA from an extinct species — the Tasmanian tiger - Vimarsana News

In a first, scientists recover RNA from an extinct species — the Tasmanian tiger

"People didn't think it could really be done," Marc Friedländer, an associate professor in molecular biology at Stockholm University, told CBS News.